Soaring Eagle Acquisition Corp. (SRNG)

RADNOR, Pa., Oct. 8, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo") f/k/a Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle").

Ginkgo Bioworks knows about growth and so far, it seems as though DNA stock does as well as it kicks off under an aptly titled ticker. The post DNA Stock Cooks Up 10% Gains on Ginkgo Biowork's First Trading Day appeared first on InvestorPlace.

BOSTON, Sept. 17, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a special purpose acquisition company, today announced the closing of their previously announced business combination.

Soaring Eagle Acquisition is about to complete its merger with Ginkgo Bioworks, and SRNG stock is reacting well. Here's why.

BioRevolution is a new and rapidly growing set of tools that are increasingly allowing us to read, write and hack that code of life with greater speed and precision and a rapidly decreasing cost. Health care is the most mature sector of those we are investing in, and even in health care, it's still early.

The synthetic biology company is going public through one of the largest SPAC mergers in history. Is the stock worth paying up for?

ARK Invest made multiple purchases of these stocks last week.

NEW YORK--(BUSINESS WIRE)-- #ginkgobioworks--Soaring Eagle Acquisition Corp., a Cayman Islands exempted company limited by shares (the “Company” or “Soaring Eagle”) (Nasdaq: SRNG.U, SRNG, SRNG WS), announced today that it has scheduled the extraordinary general meeting of the Company's shareholders (the "Special Meeting") in connection with its business combination (the "Business Combination") with Ginkgo Bioworks, Inc. to be held on September 14, 2021. Notice of the Special Meeting and a proxy statement/prospec

Ark Invest first began purchasing shares of the Ginkgo Bioworks SPAC on August 3 and now owns 14.5 million shares worth about $150 million.

Ginkgo Bioworks, Inc. and Soaring Eagle Acquisition Corp., a special purpose acquisition company, have announced their $17B merger transaction will finalize in Q3'21 resulting in Ginkgo earning a $15B EV. Ginkgo Bioworks is a high-growth analytical biotechnology company applying automation for contract-based cell engineering utilizing a combination of computational and synthetic biological practices.

Only a select few companies raised at least $1 billion from their IPOs in the first six months of 2021. Here are seven of the best.

BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1:00pm ET. The Investor Day will feature conversations with Ginkgo's Founders, a virtual Foundry Tour, presentations by Ginkgo senior management, and a showcase of customer programs.

Last week featured three announced SPAC deals. The week also had earnings from several well-known former SPACs.

Ginkgo Bioworks isn't letting any grass grow under its feet. Just a week after inking a $2.5 billion pact to go public via the special purpose acquisition company Soaring Eagle Acquisition Corp. ( SRNG , Financial), the Boston-based company is expanding overseas.

Last week featured eight announced SPAC deals. The week also had earnings from several well-known former SPACs.

Soaring Eagle: Meeting Ginkgo, One Of The Most Exciting SPAC Deals Yet